The carbonic anhydrase 1 gene is expressed in adult human and mouse erythroid cells and colon epithelia from two distinct promoters. We have explored the erythroid promoter for cis-acting sequences involved in transcription using DNAaseI as a probe. Two DNAaseI-hypersensitive sites (DHS-l and DHS-2) have been identified in the distal erythroid promoter in CAI-expressing erythroleukaemic cells. These sites are present at low levels in K562 cells, which have a foetal/embryonic phenotype and do not express CAI. DHS-1 and DHS-2 are not present in non-erythroid cells, including colon cells, which express CA] from the proximal colon promoter. DHS-1 and DHS-2 were also generated in an heterologous CA] gene containing 5 kb of erythroid promoter sequence after transfection into erythroid cells, including K562 cells. These transfection studies showed that both this fragment, and an abbreviated 817 bp promoter fragment which contains only DHS-1, were sufficient to confer erythroid-specific expression to a reporter gene. These promoters were active in cell lines expressing CA] and in K562 cells. This latter observation implies that a developmental repressor factor is both present in K562 cells and binds to a cis-acting sequence that is absent from the sequence 5 kb upstream of the erythroid transcription start site.
INTRODUCTION
Seven genes have been identified which encode carbonic anhydrase (CA) isoenzymes in mammals (Tashian, 1989) . The CA isoenzymes all perform vital functions in the cellular diffusion of C02, ion transport and pH regulation, but show differences in their sensitivities to CA inhibitors and rates of CO2 turnover (Khalifah & Silverman, 1991) . In recent years significant progress has been made towards understanding the molecular basis for these differences by mutational analyses of recombinant CA protein (Tu et al., 1989; Jewell et al., 1991) . The various isoenzymes also exhibit characteristic patterns of cell-type expression, and several studies correlating protein with mRNA levels suggest that these are regulated at the level of gene transcription (Brownson et al., 1988; Brady et al., 1990) .
Three of the genes, CA], CA2 and CA3, are clustered in the mammalian genome, near to the centromere, band 3A, in the mouse and within 150 kb of each other on human chromosome 8q22 (Beechey et al., 1990; Lowe et al., 1991) . Despite their close proximity and evident structural similarities, these three genes each exhibit a different pattern of expression during differentiation and development. CA3 is first expressed in the early mesoderm and developing notochord and later in skeletal muscle (Lyons et al., 1991) ; its proximal promoter region contains binding sites for several muscle-specific transcription factors (Edwards et al., 1992) . In contrast, CA2 is ubiquitously expressed and exhibits a characteristic housekeeping promoter (Shapiro et al., 1987) . The third gene, CA], which is the subject of the present paper, is expressed in two major sites: erythroid cells and colon epithelia (Villeval et al., 1985; Lonnerholm, 1984) . In red blood cells CA isoenzyme 1 (CAl) is the next most abundant protein to haemoglobin (10 ,ug/mg of Hb).
The CAI gene in both human and mouse is transcribed from two promoters with different tissue specificities Fraser et al., 1989) . Structural characterization of the CAI gene revealed an unusual 5' architecture (Lowe et al., 1990) , with one promoter proximal to the protein coding sequence and an additional distal promoter 36 kb upstream of the protein coding sequence. The distal promoter gives rise to high levels of CAI mRNA in reticulocytes and erythroleukemic cells (Brady et al., 1989) , whereas the proximal promoter determines expression in colon epithelial cells . The use of these promoters appears to be exclusive, such that both are never active in the same cell type. We are interested in the mechanisms and factors which specifically activate the CAl erythroid promoter and repress the colon promoter in erythroid cells.
Two particular aspects of the regulation of CA] in erythroid cells form the focus of these studies. The first is the developmentalstage-specific activation of CAI ; the second is the regulation of CAI during erythropoiesis (Villeval et al., 1985) . We (Lozzio & Lozzio, 1975; Donovan-Peluso et al., 1987) . In addition, murine erythroleukaemic (MEL) cells are useful, since they can be induced with dimethyl sulphoxide (DMSO) to undergo a differentiation process that mimics erythropoiesis (Kabat et al., 1975) and is marked by a suppression of CA] transcription (Fraser & Curtis, 1987 Elgin (1981) and Gross & Garrard (1988) ]. For example, at least ten DNAase I-hypersensitive sites (DHSs) have been characterized in the chicken lysozyme gene locus and all appear to mark sequences with a range of functions including transcriptional enhancers and silencers (Fritton et al., 1988) . Of particular note are the DHSs of the ,-globin locus control region (LCR), which mark out sequences responsible for activating the entire locus in erythroid cells (Grosveld et al., 1987) , bind trans-acting transcription factors, and confer position-independent high-level gene expression (Ney et al., 1990; Blom van Assendelft et al., 1989) .
Using DNAaseI as a probe, we have looked for sequences involved in transcription in and around the CA I gene in erythroid and non-erythroid cell lines. These studies have revealed several DHSs, at least two of which are erythroid-specific and can be generated in transfected promoter constructs.
MATERIALS AND METHODS

Cell lines
The following cell lines were used in this study: erythroleukaemic cell lines K562 (Lozzio & Lozzio, 1975) , HEL (Martin & Papayannopoulou, 1982) and MEL (Friend et al., 1971) , colon carcinoma LIM 1215 (Whitehead et al., 1985) , T lymphoblastoid CCRF-CEM (Foley, 1965) and HeLa (Gey et al., 1952) . Tissueculture practice was standard (Freshney, 1983) . HeLa, K562, HEL, and CCRF-CEM lines were maintained in Dulbecco modified Eagle medium. MEL C88 (APRT-) cells were maintained in a-minimal essential medium supplemented with diaminopurine (50 jug ml-'). All media were supplemented with 10 % (v/v) foetal-calf serum, penicillin (100 i.u.), streptomycin (100 jug ml-1), amphotericin B (2.5jug ml-1) and 2mM-glutamine.
DNAaseI-hypersensitivity assay
Nuclei were prepared from cultured cells harvested in exponential phase. Typically 7 x 107 cells were washed twice in ice-cold phosphate-buffered saline and twice in ice-cold Buffer I (0.050% (v/v) Nonidet P40/10 mM-NaCl/3 mM-MgCl2/10mM-Hepes, pH 7.5). Cellular lysis was confirmed by Trypan Blue staining. The lysate was re-suspended in 10 ml of Buffer II (10 mM-NaCI/3 mM-MgCl2/10 mM-Hepes, pH 7.5) and nuclei were twice sedimented at 1000 g through 10 ml of 30 % (w/v) sucrose dissolved in Buffer II at 4°C for 5 min. DNAaseIhypersensitivity assays were carried out on isolated nuclei (essentially as described by Enver et al., 1985) . Isolated nuclei were re-suspended in ice-cold DNAaseI buffer [100 mM-NaCl/50 mMTris (pH 8.0) / 3 mM-MgCl2 /0.1 mM-phenylmethanesulphonyl fluoride/ 1 mM-CaCl2], and aliquots were digested with a range of DNAaseI concentrations from 0.1 to 10 ug -ml-'. These reaction mixtures were incubated for 30 min at 37°C before DNAaseI digestion was terminated by the addition of EDTA (to 25 mM). RNAase was added to 20 ug * ml-' and the mixture was incubated for 30 min at 37°C; proteinase K and SDS were added to 50 jug * ml-' and 0.25 % (w/v) respectively, with further incubation for 18 h at 60 'C. Samples were extracted with phenol/chloroform and chloroform and subjected to ethanol precipitation. DNAaseI digestion patterns were analysed by Southern-blot analysis. Several fragments were isolated from CA] genomic clones (Lowe et al., 1990) . Fig. 1 shows the relationship of these probes to the genomic map of CAI and their positions relative to the erythroid transcription start site.
Plasmids
Two CAI promoter fragments, Saul to SspI (+ 14 to -817) and Saul to SmaI (+ 14 to -5.0 kb), were ligated on to the murine H2K gene and cloned into the G418 selection vector ptkAGPT (Grosveld et al., 1982) to give plasmids CAJ-SspI-H2K and CAI-SmaI-H2K respectively (see Fig. 5 below). The cloning strategy was to replace the ,-globin promoter (-815 to + 50) fragment from ,/-H2K (Antoniou et al., 1988) 
Transfections
Plasmid DNA for transfections was purified from CsCl gradients, linearized by digestion with PvuI, and ethanolprecipitated. Electroporation parameters were as follows: cultured cells were harvested in exponential phase and re-suspended to a volume of 0.7 ml in 25 mM-Hepes (pH 7.24)/140 mMNaCl/0.75 mM-Na2HPO4 (Smithies et al., 1985) and mixed with PvuI-digested plasmid H2K, ,-H2K, CAJ-SspI-H2K or CA]-SmaI-H2K resuspended in 100jul of the same buffer. Samples were left at room temperature for 10 min, electroporated at 250 V (960 uF) and left at room temperature for a further 5 min before being transferred to culture medium. Geneticin G418 sulphate was added after 48 h. The minimum concentration of Geneticin necessary to kill untransfected cells in 10 days was empirically determined for each cell line. The concentrations used were between 0.2 and 1.0 jug ml-', and resistant colonies were usually detected approx. 14 days after transfection.
Conditions were optimized to give at least 50 colonies per transfection. MEL, HEL, HeLa and CCRF-CEM cells (1.0-2.0 x 108) were each transfected with 100 jug oflinear plasmid CAI-SspI-H2K and CAI-SmaI-H2K DNA respectively and 4 x 101 K562 cells were transfected with 25 jug of the same plasmids. Fewer K562 cells were used per transfection because of their higher transfection efficiency. After selection, transfected populations of MEL cells were divided and half were induced to differentiate by culturing for 3-4 days in the presence of 1.8 % (v/v) DMSO. RNA and DNA for analysis was isolated from transfected cell populations using standard methods (Maniatis et al., 1982; Chirgwin et al., 1979) .
DNA analysis
Amplification was performed on 1 ug of DNA isolated from transfected cell populations in 100jul of Taq DNA polymerase buffer containing 50 pmol of oligonucleotide primers specific for the amplification of a 226 bp DNA fragment across the CAI-H2K construct junction. The sequences of the primers were: CA 5'-CCCACTCTAATCACCACAGG-3' (sense); H2 5'-CAACAGCAGGAGCAGCGTGC-3' (complementary). After 5 min at 95 0C, 2 units of Taq DNA polymerase were added, followed by 32 cycles of amplification (denaturation for 15 s at 94°C, annealing for 30 s at 56°C and elongation for 30 s at 72°C). Control amplifications of the same DNA samples were performed using human phosphoglycerate mutase 2 and mouse erythropoietin oligonucleotide primers Abbott, 1992 The pellet was resuspended in 50 mM-Tris/HCI (pH 8.0)/ 140 mM-KCI/6 mM-MgCl2/30 mM-/ mercaptoethanol/placental RNAase inhibitor (2 units ,ul-1)/1 mM-(all 4)dNTPs/reverse transcriptase (0.5 units ,ul-1) and incubated at 50°C for 1 h. EDTA was then added to 15 mm, followed by RNAase to 0.5 jtg ml-' and the mixture incubated for 30 min at 37 'C. The purified extension product was analysed on 8 % (w/v) polyacrylamide/50 % (w/v) urea denaturing gel.
DNAaseI to give fragments of 2.8 kb and 4.1 kb. Similar data was obtained using EcoRI and other enzymes in the postDNAaseI digest. The combined restriction mapping data locate two DHSs (DHS-1 and DHS-2) to positions approx. 200 bp and 1.5 kb upstream of the erythroid start site respectively (Figs. 1 and 2).
A comparison of the relative intensities of the DNAaseI fragments suggest that, at higher DNAaseI concentrations, most of the chromosomal DNA was cleaved either at the more 5' site, DHS-2, or at both sites simultaneously, such that the small 2.8 kb XbaI fragment or the 2.5 kb SstI fragment were the most prominent product. At lower concentrations DNAaseI cleaves at only one or the other of the DHSs or not at all, and both DNAaseI products are clearly detected (Fig. 2) .
To establish whether DHS-1 and DHS-2 are tissue-specific phenomena, DNAaseI-hypersensitivity assays were performed in parallel on nuclei isolated from CAl-expressing HEL cells, from LIM 1215 cells, which express CAI from the colon promoter and not the erythroid promoter, and from CAI-non-expressing K562 and HeLa cells. A typical experiment is shown in Fig. 3 . The appearance of two small DNAaseI products of 8.5 kb and 7.2 kb in DNAaseI/EcoRI-digested HEL-cell DNA confirmed the presence of DHS-1 and DHS-2. In contrast, the HeLa and LIM1215 (Brady et al., 1989) , whereas the colon-carcinoma cell line, LIM1215 (Whitehead et al., 1985) , expresses CAl from the proximal colon promoter (J. Sowden, unpublished work). DHSs downstream of the erythroid start site and in the region of the proximal colon promoter Restriction-enzyme mapping of DNA from HEL DNAaseItreated nuclei using 1OX-H (Fig. 1) as the probe indicated that three additional hypersensitive sites, DHS + 1, DHS + 2 and DHS + 3, are present 7 kb, 7.8 kb and 12.8 kb respectively downstream of the leader exon la, within the large 5' intron of CAI (Fig. 1) . DNAaseI cleavage of the parent 3.5 kb HindlIl fragment produced two fragments of 2.0 kb and 2.7 kb, whereas cleavage of the overlapping parent 4.5 kb XbaI fragment generates a single band of 4.0 kb (Fig. 4) . In addition a weak DHS, DHS + 4, was detected 3 kb upstream of exon lb using the 2.OX probe (Fig. 1) . These four DHSs were not present in HeLa or K562 cells. Further, DHSs were not found in erythroid cells, either in the coding regions or in the 3' flanking region of CA] using probes which spanned these regions (see the Materials and methods section and Fig. 1 HindIII and 7 kb XbaI fragments were cleaved by DNAaseI to generate an 8 kb fragment (Fig. 4) and a 3 kb fragment respectively. These products were not detected in HEL DNAaseItreated DNA.
These data from DNAaseI-hypersensitivity assays, when taken together, demonstrate that the CA] gene adopts distinctive and alternative chromatin conformations in cells which express CAI specifically from either the distal erythroid promoter or the more proximal colon promoter.
DHSs in a transfected CAI-H2K gene construct
A series of transfection experiments were carried out to establish the functional significance of DHS-1 and DHS-2 in vivo. Two constructs were made in which the CAl erythroid promoter was attached to the H2K reporter gene. One, CAISmaI-H2K, included 5 kb of 5' flanking sequence (+ 14 bp to -5.0 kb) which encompassed four binding sites for the erythroidspecific transcription factor GATA-l (Brady et al., 1989; Tsai et al., 1989) and both DHS-l and DHS-2. The other construct, CAI-SspI-H2K included only 815 bp of 5' flanking sequence (+14 bp to -817 bp) encompassing the same four GATA-1 binding sites but only DHS-1; DHS-2 was not included. The CA J-H2K plasmids were stably transfected into five different cell lines, MEL, HEL, K562, HeLa and CCRF-CEM. Transfection was confirmed by PCR amplification of a 226bp fragment specific for the CAI-H2K construct using DNA isolated from pools of Geneticin-resistant cells (Fig. 5) .
DNAaseI-hypersensitivity assays were performed on cell populations stably transfected with plasmid CAI-SmaI-H2K. Post DNAaseI digests were EcoRI/BamHI in order to distinguish the construct from the endogenous CAI DNA. A typical assay using the 1.4A probe is shown in Fig. 6 Nuclei were isolated from populations of stable transfectants and treated with DNAaseI (0.1-3.0 ,ug ml, increasing concentrations of DNAaseI as indicated by an arrow), and purified DNA was double-digested with EcoRI and BamHI and hybridized with 32P-labelled 1.4A (see Fig. 1 ). Cl and C2 are untransfected samples of K562 and MEL DNA respectively. Fragments attributed to cleavage at DHS-1 and DHS-2 are indicated by small arrows (4-).
probe, so that only the transfected construct is seen in untreated cells (Fig. 6) . Two erythroid-specific and CAI-H2K-specific DNAaseI products, 4.8 kb and 3.5 kb, were detected in chromosomal DNA from transfected MEL cells and HEL cells (HEL-cell results not shown). These bands were not seen in HeLa-cell DNA and are distinguished in size from the bands which would be expected from DNAaseI digestion of the endogenous gene. Restriction mapping indicated that the positions of these two DHS, in the CA] promoter of the CA1-H2K gene are the same as DHS-I and DHS-2 in the endogenous gene in HEL chromosomal DNA. Thus DHS-1 and DHS-2 are generated when cloned linearized CAI DNA is integrated into heterologous erythroid cells.
A striking feature of these studies is that, whereas DHS-l and DHS-2 are only weakly evident in the endogenous unexpressed CA] gene of K562 cells, transfection of K562 cells with CAlSmaI-H2K resulted in the generation of these DHS to the same extent as in equivalent transfections of CAI-expressing cells (for example, compare with MEL, Fig. 3) . In transfected samples of K562 and HeLa, but not MEL cells, two additional fragments (of 5.0 kb and 6.8 kb) were detected. The intensities of these fragments do not relate to DNAaseI concentrations, since they are found both in the control (no DNAaseI) and DNAaseI-treated samples; nor do the fragments appear to derive from the endogenous CAI gene, since they were not detected after DNAaseI treatment of untransfected cells. Thus they appear to be consequent upon the introduction of the CAJ-H2K chimaeric gene into the human cells and perhaps endogenous nuclease activity. The nature of these fragments still requires investigation. CA] 5' flanking sequences confer erythroid-specific expression on a reporter gene In order to demonstrate whether the generation of DHS-1 and DHS-2 in transfected CA] constructs was associated with transcriptional activity, RNA was isolated from pools of transfectant cells and analysed for the presence of CAJ-H2K
transcripts. An oligonucleotide, H2 (see the Materials and methods section), within the first exon of CAI-H2K was used as a primer in RNA extension analyses.
These experiments showed that both CAl-H2K constructs were transcriptionally active in an erythroid-specific manner. Deletion of DHS-2 and 4.2 kb of upstream sequence (CAI-SspI-H2K) did not alter the level of CAI-H2K expression. Of special note was the finding that CAI-H2K mRNA was detected in transfected K562 cells which do not normally express CA]. All of these features are demonstrated in Fig. 7 . A 71 nt band corresponding to CAI-H2K mRNA was detected in MEL, K562
and HEL cells transfected with both CAI-SspI-H2K and CAlSmaI-H2K, but not in transfected HeLa or CCRF-CEM cells (HEL-cell results not shown). A 56 nt product in MEL cells corresponds to mRNA transcribed from the endogenous murine H2K gene and provides an internal control; otherwise no extension products were primed from untransfected control RNA samples (C in Fig. 7) . Comparisons of the levels of the 71nt transcript relative to each other (and to the control H2K signal in MEL cells) suggest that similar levels of RNA are transcribed from both constructs. A promoterless H2K plasmid (-P in Fig.  7 ) was also transfected, but did not transcribe H2K.
Vol. 288 (Fraser et al., 1989) .
CAI promoter activity during DMSO induction of MEL cells
Stable populations of MEL cells transfected with both CAI promoter constructs were induced to undergo erythroid differentiation using DMSO (Kabat et al., 1975) . The efficiency of DMSO induction was confirmed by the down-regulation of the endogenous mouse CAI mRNA and activation of the /3-globin promoter in a parallel transfection of the ,l-H2K plasmid (Antoniou et al., 1988) (Fig. 7) . Primer extension analyses (Fig.  7) showed that the efficiency of the CA] promoter in both the CAI-H2K constructs was unaffected by DMSO, as judged by the intensity of the 71nt CA]-H2K transcript, which was present at similar levels before and after treatment (the 56nt band corresponding to the endogenous H2K transcript acts as an internal control for mRNA levels, since H2K transcription does not alter with MEL-cell differentiation ; Wright et al., 1984) .
These results suggest that the mechanism which down-regulates the endogenous mouse CA] mRNA during DMSO-induced erythroid differentiation (Fraser & Curtis, 1987) , and we now describe a region 500 bp upstream of the first coding exon which is marked by a colon-specific DHS and is potentially important in transcription. The other promoter is erythroid-specific and has been characterized in more detail; it is known to contain sequence elements which bind the erythroid transcription factor GATA-1 (Brady et al., 1989; Tsai et al., 1989; Zon et al., 1990) . In the present paper we have focused on the association between the transcriptional activity of this erythroid promoter and its local chromatin conformation. Two DHSs, DHS-1 and DHS-2, identified upstream of the erythroid start site in chromosomal DNA, were shown to be both erythroid-specific and independent of transcriptional activity. These sites were present in CA]-expressing erythroid cells and at low frequency in CA1-non expressing K562 cells. K562 cells are considered to have a foetal/embryonic erythroid phenotype with differentiation blocked at an early stage of erythropoiesis; indeed Enver et al. (1988) suggest that K562 cells are uncommitted haematopoietic stem cells. The relatively infrequent occurrence of DHS-1 and DHS-2 in K562 endogenous CA] may indicate that K562 cells are a heterogeneous population in which few cells have generated erythroid-specific DHS in their chromosomal DNA; perhaps these latter cells represent those further committed to the erythroid lineage. The notion that the cell line is heterogeneous is supported by an earlier observation that sequences around the CAI erythroid promoter in DNA from K562 cells always exhibit partial methylation (Lowe et al., 1990) . We propose that the appearance of DHS-1 and DHS-2 in certain K562 cells is an early marker for commitment to the erythroid lineage and precedes the expression of CA].
In addition to the characterization of DHS in endogenous CA] chromosomal DNA we have shown that DHS-1 and DHS-2 are specifically generated in transcriptionally active heterologous CA] genes transfected into erythroid cells. There are reports of a few other cases where DHSs have been generated in an appropriate tissue-specific manner, for example after the integration of the elastase I (Hammer et al., 1987) or f-globin (Radice & Constantini, 1986) transgenes into the mouse germ line. Currently the mechanism whereby DHSs are generated is not well understood. Significant progress has been made towards understanding this process in inducible systems; for example the generation of a DHS in the mouse mammary-tumour-virus promoter is associated with binding of hormone-receptor complex and nuclear factor-1 at the hormone-responsive element and this may be concomitant with nucleosome displacement (Cordingley et al., 1987; Pina et al., 1990 ). In the case of CA], the GATA-1 transcription factor may play a role in the generation of erythroid-specific DHS, involving nucleosome displacement and increasing accessibility to other trans-acting factors. GATA-1 is thought to play a major role in the commitment of cells to the erythropoietic pathway (Pevny et al., 1991) and occurs in all erythroid cells exhibiting DHS-1 and DHS-2 in both endogenous and in transfected cloned CA] genes. Furthermore, both DHS-1 and DHS-2 are located in the immediate region of GATA-1 motifs that fit the consensus A/TGATA/TA at -218, -190 and -1502 relative to the transcription start site, as indicated in Fig. 2 (Brady et al., 1989) . In HeLa cells, transcriptional activity or generation of DHSs is not observed, presumably because these cells lack essential erythroid-specific factors. The addition of DHS-2 to the minimal promoter did not significantly alter the CAI-H2K mRNA levels in erythroid cells. These experiments have not excluded the existence ofenhancer elements downstream of the start site which may interact with DHS-2 sequences, and indeed our studies show that CAI is a complex gene with a further four erythroid DHSs and a second (colon) promoter 
